BioCatalyst

FDMT — 4D Molecular Therapeutics, Inc. catalysts

1 verified catalyst event(s) for 4D Molecular Therapeutics, Inc. (ticker FDMT). Each is linked to its official source. Verified as of 2026-11-01.

Next verified catalyst

2027-03-01 — 4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-03 (month)
in 4mo
ESTIMATED
 READOUT
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
Phase 1/2 · Neovascular (Wet) Age-Related Macular Degeneration
 FDMT 4D Molecular Therapeutics, I 4D-150 IVT, Aflibercept IVT ClinicalTrials.gov ↗
✓ Source-checked 2026-11-01
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.